We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+1.2%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$38.6B
AUM Growth
+$669M
(+1.8%)
Cap. Flow
+$1.61B
Cap. Flow
% of AUM
4.18%
Top 10 Holdings %
Top 10 Hldgs %
13.49%
Holding
2,814
New
394
Increased
941
Reduced
1,071
Closed
396
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$550M |
| 2 |
Eli Lilly
LLY
|
+$493M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$418M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$381M |
| 5 |
Meta Platforms (Facebook)
META
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$486M |
| 2 |
Pfizer
PFE
|
+$433M |
| 3 |
Apple
AAPL
|
+$430M |
| 4 |
Tesla
TSLA
|
+$401M |
| 5 |
Roku
ROKU
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.02% |
| 2 | Healthcare | 23.8% |
| 3 | Communication Services | 9.19% |
| 4 | Financials | 8.73% |
| 5 | Consumer Discretionary | 8.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RRD
701
DELISTED
RR Donnelley & Sons Co.
RRD
| $6.01M | 0.02% |
1,169,610
-117,900
| -9% | -$629K |
|
|
XRN
702
Chiron Real Estate Inc
XRN
$514M
| $6M | 0.02% |
81,580
+5,620
| +7% | +$428K |
|
|
RC
703
Ready Capital
RC
$258M
| $5.99M | 0.02% |
415,324
+14,500
| +4% | +$220K |
|
|
CONN
704
DELISTED
Conn's Inc.
CONN
| $5.99M | 0.02% |
262,474
-85,762
| -25% | -$2.04M |
|
705
Genuine Parts
GPC
$17.1B
| $5.98M | 0.02% |
49,300
-25,500
| -34% | -$3.18M |
|
706
Replimune Group
REPL
$941M
| $5.96M | 0.02% |
201,000
-49,100
| -20% | -$1.59M |
|
|
CMRX
707
DELISTED
Chimerix, Inc.
CMRX
| $5.95M | 0.02% |
961,100
-11,000
| -1% | -$75.6K |
|
|
MRSN
708
DELISTED
Mersana Therapeutics
MRSN
| $5.94M | 0.02% |
25,200
+2,496
| +11% | +$729K |
|
709
New Mountain Finance
NMFC
$651M
| $5.92M | 0.02% |
445,100
-22,100
| -5% | -$296K |
|
710
Viking Therapeutics
VKTX
$3.7B
| $5.9M | 0.02% |
938,828
-45,400
| -5% | -$280K |
|
711
Tilly's
TLYS
$116M
| $5.88M | 0.02% |
419,600
+177,100
| +73% | +$2.69M |
|
712
Orion
OEC
$381M
| $5.86M | 0.02% |
321,196
-79,500
| -20% | -$1.42M |
|
713
Agnico Eagle Mines
AEM
$73.6B
| $5.84M | 0.02% |
112,643
-14,901
| -12% | -$867K |
|
714
Diana Shipping
DSX
$302M
| $5.83M | 0.02% |
1,459,033
+718,422
| +97% | +$2.38M |
|
715
Rocket Pharmaceuticals
RCKT
$340M
| $5.81M | 0.02% |
194,451
+18,400
| +10% | +$670K |
|
716
Arlo Technologies
ARLO
$1.6B
| $5.79M | 0.02% |
904,127
-39,300
| -4% | -$244K |
|
|
INFI
717
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $5.79M | 0.02% |
1,693,200
+527,800
| +45% | +$1.63M |
|
|
PVLA
718
Palvella Therapeutics
PVLA
$1.99B
| $5.76M | 0.01% |
+13,934
| New | +$4.85M |
|
719
MidCap Financial Investment
MFIC
$787M
| $5.76M | 0.01% |
443,920
-66,167
| -13% | -$901K |
|
720
Appian
APPN
$1.98B
| $5.75M | 0.01% |
62,152
+23,300
| +60% | +$2.58M |
|
|
ENDP
721
DELISTED
Endo International plc
ENDP
| $5.75M | 0.01% |
1,774,791
+1,711,800
| +2,718% | +$6.05M |
|
722
Innospec
IOSP
$2.12B
| $5.74M | 0.01% |
68,200
+35,600
| +109% | +$3.17M |
|
723
Alphatec Holdings
ATEC
$1.46B
| $5.73M | 0.01% |
469,700
-109,800
| -19% | -$1.53M |
|
724
Elastic
ESTC
$6.84B
| $5.71M | 0.01% |
38,300
+5,700
| +17% | +$877K |
|
725
National Beverage
FIZZ
$2.96B
| $5.7M | 0.01% |
108,500
+65,900
| +155% | +$3.07M |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, Two Sigma Advisers held 2,814 positions worth $38.6B, up 1.8% from $37.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Two Sigma Advisers deployed $1.61B of net new capital in Q3 2021, opening 394 new positions and adding to 941 existing holdings. Its largest new stake was Danaher: 1,248,470 shares worth $337M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 20% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $486M trimmed.
- Two Sigma Advisers's largest Q3 2021 buy was Danaher: 1,248,470 shares worth $337M.
- Two Sigma Advisers added most to Microsoft in Q3 2021, an estimated $550M increase.
- Two Sigma Advisers's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $486M.
- Two Sigma Advisers fully exited Roku in Q3 2021, selling an estimated $374M.
- Two Sigma Advisers's ten largest holdings make up 13% of its $38.6B portfolio in Q3 2021.
- Two Sigma Advisers opened 394 new positions and closed 396 in Q3 2021.
- Two Sigma Advisers's portfolio value rose 1.8% quarter-over-quarter to $38.6B.
Based on Two Sigma Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.